Tech Company Financing Transactions

Alcresta Therapeutics Funding Round

Alcresta Therapeutics secured a $10 million Series A funding round on 4/18/2012. Backers included Bessemer Venture Partners, Frazier Healthcare Partners and Third Rock Ventures.

Transaction Overview

Company Name
Alcresta Therapeutics
Announced On
4/18/2012
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors

Bessemer Venture Partners (Lead Investor) (Stephen Kraus)

Frazier Healthcare Partners (Lead Investor) (James Topper)

Third Rock Ventures (Lead Investor) (Robert Tepper)

Proceeds Purpose
Proceeds from the financing will support Alcresta in leveraging its existing proprietary platform to discover and develop a broad range of enzyme-based nutritional products and medical devices designed to improve clinical outcomes, enhance quality of life and reduce health care costs.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Newton Executive Park 100
Newton, MA 02462
USA
Phone
(617) 431-3600
Website
www.alcresta.com
Email Address
[email protected]
Overview
Alcresta's enzyme expertise and proprietary platform enables novel products for those with compromised pancreatic output and malabsorption.
Profile
Alcresta Therapeutics LinkedIn Company Profile
Social Media
Alcresta Therapeutics Company Twitter Account
Company News
Alcresta Therapeutics News
Facebook
Alcresta Therapeutics on Facebook
YouTube
Alcresta Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Daniel Orlando
  Daniel Orlando LinkedIn Profile  Daniel Orlando Twitter Account  Daniel Orlando News  Daniel Orlando on Facebook
Chief Financial Officer
Tasos Konidaris
  Tasos Konidaris LinkedIn Profile  Tasos Konidaris Twitter Account  Tasos Konidaris News  Tasos Konidaris on Facebook
Chief Scientific Officer
Eric First
  Eric First LinkedIn Profile  Eric First Twitter Account  Eric First News  Eric First on Facebook
VP - General Counsel
William Scheinler
  William Scheinler LinkedIn Profile  William Scheinler Twitter Account  William Scheinler News  William Scheinler on Facebook
VP - Sales
Darbi James
  Darbi James LinkedIn Profile  Darbi James Twitter Account  Darbi James News  Darbi James on Facebook

 

 

Browse more venture capital transactions:

Prev: 4/18/2012: Eucalyptus Systems venture capital transaction
Next: 4/18/2012: Gridco Systems venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We record every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.